BIOCON.NSE logo

BIOCON.NSE
Biocon

733
Loading...
Loading...

About

Biocon Ltd. is a holding company, which engages in the manufacture, research, and development of therapeutic drugs. It operates through the following segments: Small Molecules, Biologics, Branded Formulations, and Research Services. The Small Molecules segment manufactures spanning statins, immunosuppressants, antifungals, anti-obesity, anti-diabetics, ophthalmologicals, oncologicals, and urologicals etc. The Biologics segment provides Insulins and Analogs, biosimilar Monoclonal Antibodies (MAbs), and recombinant proteins The Branded Formulation segment consists of therapeutic areas of diabetology, oncology, immunology and critical care. The Research Services segment covers Syngene development platforms. The company was founded by Kiran Mazumdar-Shaw on November 29, 1978 and is headquartered in Bangalore, India.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Biocon Ltd.?
What is the 52-week high for Biocon Ltd.?
What is the 52-week low for Biocon Ltd.?
What is Biocon Ltd. stock price today?
What was Biocon Ltd. stock price yesterday?
What is the PE ratio of Biocon Ltd.?
What is the Price-to-Book ratio of Biocon Ltd.?
What is the 50-day moving average of Biocon Ltd.?

Latest BIOCON.NSE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.